SRPK1 has been previously characterized to drive cell proliferation, migration, and invasion in colorectal and gastric cancers [50–53] suggesting that the fusion protein may have oncogenic consequences in the SNUC cell line. The gene discussed is SRPK1; the disease is gastric cancer.